Multiple Behavior Phenotypes of the Fragile-X Syndrome Mouse Model Respond to Chronic Inhibition of Phosphodiesterase-4D (PDE4D)

por Gurney, Mark E., Cogram, Patricia, Deacon, Robert M, Rex, Christopher, Tranfaglia, Michael
Publicado 2017

Open-label add-on treatment trial of minocycline in fragile X syndrome

por Paribello, Carlo, Tao, Leeping, Folino, Anthony, Berry-Kravis, Elizabeth, Tranfaglia, Michael, Ethell, Iryna M, Ethell, Douglas W
Publicado 2010

Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X mice

por Cogram, Patricia, Alkon, Daniel L., Crockford, David, Deacon, Robert M. J., Hurley, Michael J., Altimiras, Francisco, Sun, Miao-Kun, Tranfaglia, Michael
Publicado 2020

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1(KO) Mice

por Westmark, Cara J., Westmark, Pamela R., O'Riordan, Kenneth J., Ray, Brian C., Hervey, Crystal M., Salamat, M. Shahriar, Abozeid, Sara H., Stein, Kelsey M., Stodola, Levi A., Tranfaglia, Michael, Burger, Corinna, Berry-Kravis, Elizabeth M., Malter, James S.
Publicado 2011